Ladenburg initiated coverage of NeuroOne Medical (NMTC) with a Buy rating and $1.45 price target
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NMTC:
- NeuroOne Medical completes FDA submission for OneRF Ablation System RF
- NeuroOne Medical confirms ‘no material impact’ from global tariffs
- NeuroOne Medical sees FY25 product revenue $8M-$10M vs. $3.5M last year
- NeuroOne Medical’s OneRF technology featured in Fox News story
- NeuroOne Medical 16M share Spot Secondary priced at 50c